drugset / Trial / NCT03313414

HCV Post-Exposure Prophylaxis for Health Care Workers

NCT03313414 ↗

NaSingle-groupOpen-labelPrevention

Summary

This is an unblinded, observational trial of sofosbuvir-velpatasvir in adult health care workers who are exposed to hepatitis C virus from needlestick injury with hollow-bore needles.

Timeline

Start
2019-08-13
Primary completion
2020-01
Completion
2020-01-16

Outcome

Outcome not reported

Stopped (Enrollment): “No participant enrollment, funding withdrawn.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sofosbuvir/Velpatasvir Unknown — —